Brief: Imagion Biosystems Secures AU$3.75M In Capital Raise Following FDA Clearance Of Phase 2 Clinical Trial
25/06/2026 18:44
BRIEF-Imagion Biosystems Secures AU$3.75M In Capital Raise Following FDA Clearance Of Phase 2 Clinical Trial June 25 (Reuters) - Imagion Biosystems Ltd IBX.AX:
IMAGION BIOSYSTEMS SECURES AU$3.75M IN CAPITAL RAISE FOLLOWING FDA CLEARANCE OF PHASE 2 CLINICAL TRIAL
Source text: ID:nBwbtB2rra
Further company coverage: IBX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Imagion Biosystems
See all newsBrief: Imagion Biosystems Secures AU$3.75M In Capital Raise Following FDA Clearance Of Phase 2 Clinical Trial
Brief: Imagion Biosystems Secures A$3.75 Million In Firm Commitments Under Capital Raising
Australia's Imagion Biosystems falls on discounted placement
Brief: Imagion Biosystems Seeks Trading Halt
Australia's Imagion Biosystems surges on US regulatory win for imaging agent